Able Suspends Product Shipments Due To GMP Compliance Concerns
Executive Summary
Able Laboratories is temporarily suspending shipment of all products until the company can guarantee the drugs have been manufactured in accordance with current good manufacturing practices, the company said May 19
You may also be interested in...
Able files for bankruptcy
Able Labs files petition to reorganize under Chapter 11 in U.S. Bankruptcy Court in Trenton, N.J. The company is not currently generating revenue after manufacturing problems caused it to voluntarily suspend drug production and all product shipments in May (1"The Pink Sheet" May 23, 2005, p. 28)...
Able files for bankruptcy
Able Labs files petition to reorganize under Chapter 11 in U.S. Bankruptcy Court in Trenton, N.J. The company is not currently generating revenue after manufacturing problems caused it to voluntarily suspend drug production and all product shipments in May (1"The Pink Sheet" May 23, 2005, p. 28)...
FDA Cites Able For Failing To Reject Out-Of-Specification Drugs, Altering Data
Able Labs routinely failed to reject drugs that did not meet established standards, specifications and quality control criteria, according to FDA inspectional observations included in a "Form 483" report